Loading...
Loading...
BJDX| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 160.3K |
| Gross Profit | -160.3K |
| Operating Expense | 2,679.6K |
| Operating I/L | -2,839.9K |
| Other Income/Expense | 139.7K |
| Interest Income | 0.0K |
| Pretax | -2,539.8K |
| Income Tax Expense | -300.1K |
| Net Income/Loss | -2,239.8K |
Bluejay Diagnostics, Inc. is a diagnostic company in the United States, specializing in patient products for triage, diagnosis, and disease monitoring. The company's revenue is generated through the development and marketing of the Symphony platform, which includes the Symphony Fluorescence Immuno-analyzer for blood processing and immunoassay preparation, and the Symphony Cartridge Library with reagents and components. Additionally, it offers the ALLEREYE diagnostic test for allergic conjunctivitis and is involved in the development of biomarkers for diseases such as myocardial injury and cardiac heart failure. Bluejay Diagnostics, Inc. also has a license and supply agreement with Toray Industries, Inc. for protein detection chips.
